FT.com / Search

1-10 of 11 results for Novartis Pharmaceuticals Corporation

Sort by:

Relevance
Date

December 1, 2009
Drugs groups face increase in tax rates
Pharmaceuticals companies are set to face “significant” increases...companies. The consultancy highlighted wide variations in corporation tax rates currently paid by the large drugs manufacturers...Bayer of Germany to as low as just 14 per cent for Novartis of Switzerland. In the US, it showed that pharmaceuticals including biotechnology remained among the lowest... By Andrew Jack in London
December 1, 2009
Drugs groups face increases in tax rates
...domestic research and development by large foreign companies. The consultancy highlighted wide variations in corporation tax rates currently paid by the large drugs manufacturers, ranging from 29.3 per cent in 2008 for Bayer of Germany to as low as just 14 per cent for Novartis of Switzerland. In the US, it showed that pharmaceuticals including biotechnology remained among the lowest taxed corporate sectors at 32.5 per cent. Among the large... By Andrew Jack in London
August 1, 2005
Generics embrace globalisation
...recently lost its number-one spot to Novartis after the Swiss group paid $8...You can't meet the demand for pharmaceuticals by using innovative [brand name...as Mylan Laboratories and Watson Pharmaceuticals. "Years after Mylan and Watson...Names mentioned include Barr Pharmaceuticals, Andrx Corporation, Mylan, Watson, of the US... By Christopher Bowe
June 22, 2008
From Insead to Africa
...Gera, now a mother of three. Mr Bar-Gera found a position in information technology at Sandoz, the Swiss pharmaceuticals group that later merged with Ciba-Geigy to form Novartis. His wife got a job at UBS in Zurich as an investment banker. Both soon realised, however, that they were not “big company” people. “It took me three years to understand what it meant, working in a large corporation,” says Mr Bar-Gera. His final role at Sandoz was as finance director of the Swisssubsidiary. Confidence... By Haig Simonian
July 22, 2005
Ironies of French resistance to PepsiCo
...The defence of national champions is a particularly French obsession. A similar campaign last year persuaded Novartis, the Swiss pharmaceuticals group, not to bid for Aventis against Sanofi, a French rival. There was also soul-searching over the fate...security expands. The US, for example, is agonising over the merits of allowing China National Offshore Oil Corporation to buy Unocal. It also paused over the recent sale by IBM of its personal computer business to China’s to... By John Willman
June 23, 2008
Africa beckons for serial entrepreneurs
...Gera, now a mother of three. Mr Bar-Gera found a position in information technology at Sandoz, the Swiss pharmaceuticals group that later merged with Ciba-Geigy to form Novartis. His wife got a job at UBS in Zurich as an investment banker. Both soon realised, however, that they were not "big company" people. "It took me three years to understand what it meant, working in a large corporation," says Mr Bar-Gera. His final role at Sandoz was as finance director of the Swiss subsidiary. Insead, they... By Haig Simonian
March 10, 2007
Huntsworth spends $50m on US healthcare PR
...the public relations group, highlighted the robust state of healthcare marketing by acquiring Dorland Global Corporation, a US healthcare marketer, for up to $50m (£25.9m) cash. The acquisition involves an initial consideration...more than double headcount in Huntsworth Health, substantially increasing its presence in the US, the largest pharmaceuticals market. In the UK, most healthcare marketing involves public relations and other disciplines aimed at medical...whereas in the US brands have more room to market directly to consumers. Dorland works for clients including Novartis, Schering-Plough and Procter and Gamble. By Carlos Grande,Marketing Correspondent
November 22, 2005
Germany loses big company crown to Swiss
...changing European corporate landscape as car manufacturers, engineering groups and chemical companies give ground to pharmaceuticals and telecommunications companies and once-insignificant economies such as Spain and Finland emerge on to the...Allianz, Deutsche Bank, Bayer, BASF and Hoechst. The two other top 10 companies in those days were the Swiss Bank Corporation (now UBS) and Italy’s Assicurazioni Generali. Shell would still have featured as continental Europe’s biggest...1985 before two big mergers pushed it up the league tables. Total is followed by four Swiss multinationals – Novartis, Nestlé, Roche and UBS – giving Switzerland the biggest share in the top 10 and confirming the country... By Paul Betts in Paris
November 15, 2005
Biggest M&A boom since 2000 coming
...rumour of a £3.6bn deal between Hilton Hotels Corporation of the US and Hilton Group of the UK. That has...Online this year, but those talks were abandoned. Pharmaceuticals UK investors also look to the US in this sector...larger rival GlaxoSmithKline. Fellow drug group Shire Pharmaceuticals is also mentioned on the City rumour mill. SkyePharma...However, investors remain hopeful that the likes of Novartis of Switzerland will buy the company. Utilities Investment... By Lina Saigol and Robert Orr
February 22, 2006
UBS takes centre stage at European awards
...in the Gulf of Mexico and is investing in the Polish retail market. Also shortlisted: Mol, OMV, PKN Orlen. Pharmaceuticals and chemicals: BASF, the German chemicals company, won praise for always being in the top three, if...Tronchetti Provera, chairman, Telecom Italia, Pirelli and Olimpia; Daniel Vasella, chairman and chief executive, Novartis; Ben Verwaayen, chief executive, BT Group; Lionel Barber, editor, FT; Burkhard Schwenker, chief executive...investment banking, where UBS has expanded sharply through acquisitions. The product of the merger of Swiss Banking Corporation and the former Union Bank of Switzerland, the group has expanded fast, notably through the take over in 2000... By Brian Groom